ID Biomedical - Elephant Hunting?? (IDBEF) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ID Biomedical - Elephant Hunting?? (IDBEF)

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: Kaiser Soza who wrote ()	1/14/1999 2:24:00 AM
From: Ignite44	Read Replies (1) of 27

Kaiser, sorry I'm not a biotech expert but I do have a couple of questions... According to a recent news release, clinical trials of MRSA (methicillin resistant staphylococcus aureus) test were a success and IDBEF will file for FDA approval in February. From the press release, MRSA is a common cause of infection in hospital patients and the faster it can be diagnosed, the better. This new test cuts the diagnosis time from 1 to 2 days after the initial 24 hour culture to 90 minutes. I got this information from IDBEF's website: 204.174.26.54 What's not available there is information about competition for this market. Do you (or anyone) have information about other tests being developed that will compete with this one? Do you know if this test will also identify regular staphylococcus aureus or is it only specific for the methicillin resistant bug? Thanks

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext